EV Biologics (EV Biologics) Total Inventories : $0.13 Mil (As of Dec. 2017)

View and export this data going back to 2015. Start your Free Trial

What is EV Biologics Total Inventories?

EV Biologics's total inventories for the quarter that ended in Dec. 2017 was $0.13 Mil. EV Biologics's average total inventories from the quarter that ended in Jun. 2017 to the quarter that ended in Dec. 2017 was $0.17 Mil.

In Ben Graham's calculation of Net-Net Working Capital, inventory is only considered worth half of its book value. EV Biologics's Net-Net Working Capital per share for the quarter that ended in Dec. 2017 was $-3.11.

Days Inventory indicates the number of days of goods in sales that a company has in the inventory. EV Biologics's Days Inventory for the three months ended in Dec. 2017 was 0.70.

Inventory Turnover measures how fast the company turns over its inventory within a year. EV Biologics's Inventory Turnover for the quarter that ended in Dec. 2017 was 130.66.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. EV Biologics's Inventory-to-Revenue for the quarter that ended in Dec. 2017 was 0.00.

EV Biologics Total Inventories Historical Data

The historical data trend for EV Biologics's Total Inventories can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

EV Biologics Total Inventories Chart

EV Biologics Annual Data

Trend

Jun13

Jun14

Jun15

Jun16

Jun17

Total Inventories

0.31

0.42

0.36

0.37

0.21

EV Biologics Quarterly Data
	Jun13	Sep13	Dec13	Mar14	Jun14	Sep14	Dec14	Mar15	Jun15	Sep15	Dec15	Mar16	Jun16	Sep16	Dec16	Jun17	Dec17
Total Inventories	Get a 7-Day Free Trial												0.37	0.90	0.30	0.21	0.13

EV Biologics Total Inventories Calculation

Total Inventories includes the raw materials, work-in-process goods and completely finished goods of a company. It is a portion of a company's current assets.

EV Biologics (OTCPK:YECO) Total Inventories Explanation

Inventory control is an important part of business operation. If a company does not have enough inventory, it may not be able to meet customers' required delivery time. If it has too much inventory, the cost of holding the inventory can be high.

1. In Ben Graham's calculation of Net-Net Working Capital (NNWC), inventory is only considered worth half of its book value.

EV Biologics's Net-Net Working Capital Per Share for the quarter that ended in Dec. 2017 is

	Net-Net Working Capital Per Share (Q: Dec. 2017 )
=	(Cash And Cash Equivalents	+	0.75 * Accounts Receivable	+	0.5 * Total Inventories	-	Total Liabilities
-	Preferred Stock	-	Minority Interest)	/	Shares Outstanding (EOP)
=	(8.387	+	0.75 * 1.032	+	0.5 * 0.125	-	16.719
-	0	-	0)	/	2.41107
=	-3.11

2. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

EV Biologics's Days Inventory for the three months ended in Dec. 2017 is calculated as:

Days Inventory	=	Average Total Inventories (Q: Dec. 2017 )	/	Cost of Goods Sold (Q: Dec. 2017 )	*	Days in Period
	=	0.167	/	21.821	*	365 / 4
	=	0.70

3. Inventory Turnover measures how fast the company turns over its inventory within a year.

EV Biologics's Inventory Turnover for the quarter that ended in Dec. 2017 is calculated as

Inventory Turnover	=	Cost of Goods Sold (Q: Dec. 2017 )	/	Average Total Inventories (Q: Dec. 2017 )
	=	21.821	/	0.167
	=	130.66

4. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

EV Biologics's Inventory to Revenue for the quarter that ended in Dec. 2017 is calculated as

Inventory-to-Revenue	=	Average Total Inventories (Q: Dec. 2017 )	/	Revenue (Q: Dec. 2017 )
	=	0.167	/	38.723
	=	0.00

Be Aware

Manufacturers with durable competitive advantages have the advantage that the products they sell do not change, and therefore will never become obsolete. Buffett likes this advantage.

When identifying manufacturers with durable competitive advantage, look for inventory and net earnings that rise correspondingly. This indicates that the company is finding profitable ways to increase sales which called for an increase in inventory.

Manufacturers with inventories that spike up and down are indicative of competitive industries subject to boom and bust.

EV Biologics Total Inventories Related Terms

Thank you for viewing the detailed overview of EV Biologics's Total Inventories provided by GuruFocus.com. Please click on the following links to see related term pages.

EV Biologics (EV Biologics) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » EV Biologics Inc (OTCPK:YECO) » Definitions » Total Inventories

Comparable Companies

XCNQ:NIRV ENVB BLCM NLSP BRTX ADTX XKRX:066830 ALLR XMAD:ADL ARTL

Traded in Other Exchanges

N/A

Address

1621 Central Avenue, Cheyenne, WY, USA, 82001

Website

https://www.evbiologics.com

EV Biologics Inc is developing the extraordinary biological properties of extracellular vesicles (EVs) to create the next generation of diagnostic modalities and safe, effective biotherapeutics to improve outcomes of serious clinical conditions, increase natural longevity and transform lives.

Executives

Daniel S Mckinney	director, 10 percent owner, officer: CEO	TWO IFC, 19TH FLOOR, 8 FINANCE STREET, CENTRAL, HONG KONG F4 000000
Michael W Harlan	director	C/O WASTE CONNECTIONS, INC., 610 APPLEWOOD CRESCENT, SUITE 200, VAUGHAN A6 L4K 0C3